In this respect, our findings are consistent with previous data that SREBP1 is highly expressed in many cancers, including pancreatic cancer, breast cancer, endometrial cancer, prostate, and gastric cancer, and is associated with tumorigenesis [16–20]. This evidence concerns the gene SREBF1 and breast carcinoma.